Protagenic Therapeutics于2月17日与前Phytanix股东达成和解协议——SEC文件披露

美股速递
Feb 24

Protagenic Therapeutics Inc(股票代码:PTIX)近日在提交给美国证券交易委员会(SEC)的文件中披露,公司已于2月17日与前Phytanix股东正式签署和解协议。该协议标志着双方就过往争议达成法律层面的解决方案,具体条款未对外公开。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10